TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Urinary ratio of 6beta‐hydroxycortisol to cortisol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Diurnal intraocular pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: MVPA (Moderate to Vigorous Physical Activity)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of cholera in unvaccinated adults
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Hourly mean glucose area under the median curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Time in glucose target range (>70 to ≤180 mg/dL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Glucose variability (interquartile range and mean amplitude of glucose excursions)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of PDA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Ductal size
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: LA/Ao ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Establishment and maintenance of osseointegration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Mean stability values (PTVs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: grip strength performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preconception lifestyle score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Awareness about preconception lifestyle
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: NPI Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Depressive symptoms measured by GDS
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Clinical response correlation with heat shock protein 70
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: foot COP excursions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GHQ-28 scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Present State Examination symptom scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfaction with aspects of care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Long-term therapeutic efficacy
Endpoint domain: Mortality/survival
Primary endpoint: Adjusted mean decrease in HbA(1c)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in plasma zinc concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: arousal
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: overall satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: DQoL
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Complete control of acute nausea
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete control of delayed nausea
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mortality in individuals with diabetes
Endpoint domain: Mortality/survival
Primary endpoint: Time to head lifting
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to orientation to time and place
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Remission according to SDAI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parental intentions to self-check restraints
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Perceived behavioral control regarding self-checking restraints
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: unplanned admissions
Endpoint domain: Adverse events/effects
Primary endpoint: unplanned surgical evacuations
Endpoint domain: Adverse events/effects
Primary endpoint: complete spontaneous expulsion of products of conception
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in NTx levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in P1NP levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment Behaviour: Illness or Injury
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Knowledge: Treatment Regimen
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: peak blood alcohol concentration (BAC) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response to cyclosporine‐A
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of new non-vertebral fractures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Prediction score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Plasma noradrenaline concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Postoperative Fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Flexural strength of heat-polymerized acrylic denture base resin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Caretaker quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of symptom-free days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Outcome
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Functional sympatholysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Survival rate at 1 year follow-up
Endpoint domain: Mortality/survival
Primary endpoint: Peak oxygen uptake reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak work rate reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concerns of a serious disease
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Avoidance and restricted personal life
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: GMT responses for HPV-16 and HPV-18
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: treatment continuation
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Fatigue prevalence
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Transmyocardial gradient of oxygen content indexed to left ventricular mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: A1PI plasma concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognitive score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Percentage of female subjects with sUA levels <6.0 mg/dl
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Right ventricular function (RVSWI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: days to third available appointment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: continuity (match between primary care physician and patient)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: bone level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Chance of cure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PaO2/FiO2 values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Mechanical ventilation time
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Intensive care unit time
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Lowering criterion count scores and diagnoses for conduct disorder, ADHD, and externalizing disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lowering antisocial behavior scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Analgesic consumption of morphine hydrochloride
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: pVL nadir <20 copies/ml
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: virologic failure
Endpoint domain: Adverse events/effects
Primary endpoint: long-term mortality reduction
Endpoint domain: Mortality/survival
Primary endpoint: Peak early velocity of mitral inflow (E)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Complete virological response (CVR) at week 48
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alanine aminotransferase normalization at week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean time from initiation of induction to vaginal delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent of patients delivered vaginally by 12, 18, and 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Primary cesarean delivery rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximal dynamic strength improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cross-sectional muscle area increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PISQ-12 scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: mean speech‐in‐noise performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sound quality ratings for the 'new' hearing aid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall preference for the 'new' hearing aid
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: proportion of solid microemboli
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients with HSV-1 recurrences
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Mean time to pain cessation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of children carrying penicillin-resistant S. pneumoniae
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of children carrying penicillin-susceptible S. pneumoniae
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: mMASI score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Antera® 3D‐assessed melanin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: recurrent ischemic stroke
Endpoint domain: Mortality/survival
Primary endpoint: Mean motilin increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Gastric residue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Blood Pressure changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of postoperative AF episodes
Endpoint domain: Mortality/survival
Primary endpoint: Left Ventricular End-Diastolic Volume Index (LVEDVI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: LRR-free survival
Endpoint domain: Mortality/survival
Primary endpoint: Total glycine absorption
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Thoracic fluid content
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in liver and kidney functions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Reduction of serum malondialdehyde (MDA) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of superoxide dismutase (SOD) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 30-day operative mortality rate
Endpoint domain: Mortality/survival
Primary endpoint: left ventricle ejection fraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: ambulatory performance scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall number of invasive and non-invasive recurrences
Endpoint domain: Mortality/survival
Primary endpoint: Micronucleated cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Genotoxic damage to buccal epithelial cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PANSS positive subscale score change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Eruption of the permanent canine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain and discomfort reported
Endpoint domain: Adverse events/effects
Primary endpoint: Mean eruption time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VO2(max)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Isokinetic power and strength of shoulder and knee
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: knee flexor strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in fatigue impact
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Increase in self-efficacy for performing energy conservation strategies
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Increase in Vitality subscale of SF-36
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Rate of change in the minimal diameter of diseased segments
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Hospitalizations for clinical cardiac events
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Weight Loss (WL) ≥5%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hunger AUC reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PGA clear or almost clear
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for postnatal steroid use for chronic lung disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Waist-hip ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bioavailability of FLCZ
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean visit adherence
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: glycated hemoglobin reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality-of-life score improvement
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Left ventricular end-diastolic diameter (LVEDD) reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: enhanced measures of disease activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Thigh muscle mass preservation/increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Ferritin concentration increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Pulse Wave Velocity (ΔPWV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in MMP‐3 concentration (ΔMMP‐3)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in TIMP‐1 concentration (ΔTIMP‐1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Leg extension power
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: walking behavior
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of pain on injection
Endpoint domain: Adverse events/effects
Primary endpoint: intensity of pain
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of clinically significant displacement greater than 5 mm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maintaining healing of erosive esophagitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Preventing recurrence of symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Hospital visits
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Presenteeism
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: postoperative cognitive dysfunction (POCD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sedation Score during procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for intravenous sedation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: regional cerebral oxygen saturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: number of thromboembolic events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: number of major bleeding events
Endpoint domain: Adverse events/effects
Primary endpoint: Successful induction of labor
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Induction-active labor interval
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Mean reduction in PSQI total score
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Improved sleep latency
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Improved sleep efficiency
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Nasal volume decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Swelling of the inferior turbinate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Nasal eosinophil cell concentration increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Association of Kir6.2 E23K variant with Type 2 diabetes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of febrile infection
Endpoint domain: Adverse events/effects
Primary endpoint: mean period for normalization of urinalysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decreased time spent sitting
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: any violence from paying partners
Endpoint domain: Adverse events/effects
Primary endpoint: physical violence from paying partners
Endpoint domain: Adverse events/effects
Primary endpoint: sexual violence from paying partners
Endpoint domain: Adverse events/effects
Primary endpoint: Physical aspects of health-related quality of life
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: mean arterial oxygen tension
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hemoglobin desaturation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall complication rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean score of neuroanatomical knowledge
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: self-poisoning events
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: psychiatric admissions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: bed days saved
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: HI titers ≥1:40 after 2 injections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Seroconversion rates after 2 injections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: relief of radicular leg pain and/or low back pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participation in leisure-time physical activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement of preoperative symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Less severity of neurotological abnormalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in attention
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: blood glucose area under the curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: mean ratings of desire to eat
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing